These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14531175)

  • 1. Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus).
    Kramer L; Bauer E; Schenk P; Steininger R; Vigl M; Mallek R
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):599-603. PubMed ID: 14531175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver support in acute liver failure.
    Hughes RD
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):547-8. PubMed ID: 14531165
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracorporeal treatment in fulminant hepatic failure: pathophysiologic considerations.
    Kramer L; Bauer E
    Int J Artif Organs; 2002 Oct; 25(10):929-34. PubMed ID: 12456033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation.
    Caballero F; Lopez-Navidad A; Cotorruelo J; Txoperena G
    Transplantation; 2002 Aug; 74(4):532-7. PubMed ID: 12352914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute liver failure.
    Kramer L
    Wien Klin Wochenschr; 2004 Feb; 116(3):67-81. PubMed ID: 15008314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure.
    Rozga J; Podesta L; LePage E; Hoffman A; Morsiani E; Sher L; Woolf GM; Makowka L; Demetriou AA
    Lancet; 1993 Oct; 342(8876):898-9. PubMed ID: 8105168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detoxification as a treatment goal in hepatic failure.
    Kramer L; Kodras K
    Liver Int; 2011 Sep; 31 Suppl 3():1-4. PubMed ID: 21824274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-flow-rate haemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure.
    Sadamori H; Yagi T; Inagaki M; Shima Y; Matsuda H; Tanaka N; Sakaguchi K; Tsuji T; Matsumi M; Katayama H; Hirakawa N
    Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):435-9. PubMed ID: 11943960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure.
    Kodali S; McGuire BM
    Clin Liver Dis; 2015 Aug; 19(3):565-76. PubMed ID: 26195209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of children with cerebral edema caused by fulminant hepatic failure.
    Alper G; Jarjour IT; Reyes JD; Towbin RB; Hirsch WL; Bergman I
    Pediatr Neurol; 1998 Apr; 18(4):299-304. PubMed ID: 9588523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorption.
    Rifai K; Das A; Rosenau J; Ernst T; Kretschmer U; Haller H; Fliser D; Manns MP
    Artif Organs; 2010 Feb; 34(2):166-70. PubMed ID: 19817727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant hepatic failure post liver transplantation: clinical syndromes, correlations and outcomes.
    McCaughan GW; Huynh JC; Feller R; Painter D; Waugh R; Sheil AG
    Transpl Int; 1995; 8(1):20-6. PubMed ID: 7888047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.
    Novelli G; Rossi M; Pretagostini R; Poli L; Novelli L; Berloco P; Ferretti G; Iappelli M; Cortesini R
    Liver; 2002; 22 Suppl 2():43-7. PubMed ID: 12220303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver support in fulminant liver failure after hemorrhagic shock.
    Faybik P; Hetz H; Krenn CG; Baker A; Germann P; Berlakovich G; Steininger R; Steltzer H
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):595-8. PubMed ID: 14531174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critically ill liver patient: fulminant hepatic failure.
    McGuire BM
    Semin Gastrointest Dis; 2003 Jan; 14(1):39-42. PubMed ID: 12610854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral oedema in fulminant hepatic failure.
    Lockhart-Wood K
    Nurs Crit Care; 1996; 1(6):283-5. PubMed ID: 9594132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variability of the clinical expression of Ecstasy-induced hepatotoxicity].
    Núñez O; Bañares R; Barrio J; Menchén L; Diego Ad; Salinero E; Clemente G
    Gastroenterol Hepatol; 2002 Oct; 25(8):497-500. PubMed ID: 12361531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MARS (Molecular Adsorbent Recycling System) as a novel hepatic detoxification procedure until orthotopic liver transplantation].
    Ullerich H; Avenhaus W; Menzel J; Dietl KH; Domschke W; Lerch MM
    Z Gastroenterol; 2001 Dec; 39(12):1023-6. PubMed ID: 11753787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death from hyponatraemia-induced cerebral oedema associated with MDMA ("Ecstasy") use.
    O'Connor A; Cluroe A; Couch R; Galler L; Lawrence J; Synek B
    N Z Med J; 1999 Jul; 112(1091):255-6. PubMed ID: 10448984
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver transplantation for ecstasy-induced fulminant hepatic failure.
    De Carlis L; De Gasperi A; Slim AO; Giacomoni A; Corti A; Mazza E; Di Benedetto F; Lauterio A; Arcieri K; Maione G; Rondinara GF; Forti D
    Transplant Proc; 2001 Aug; 33(5):2743-4. PubMed ID: 11498145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.